Lantern Wealth Advisors, LLC Ab Cellera Biologics Inc. Transaction History
Lantern Wealth Advisors, LLC
- $154 Billion
- Q4 2024
A detailed history of Lantern Wealth Advisors, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Lantern Wealth Advisors, LLC holds 18,000 shares of ABCL stock, worth $45,179. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,000
Previous 23,300
22.75%
Holding current value
$45,179
Previous $60.6 Million
12.94%
% of portfolio
0.03%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding ABCL
# of Institutions
150Shares Held
132MCall Options Held
156KPut Options Held
346K-
Baker Bros. Advisors LP New York, NY27.5MShares$69.1 Million0.73% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL15.7MShares$39.3 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$33.5 Million0.01% of portfolio
-
Baillie Gifford & CO11.2MShares$28.1 Million0.02% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$26.7 Million0.03% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $716M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...